These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 33789621

  • 1. Tight junction protein ZO-1 in Kawasaki disease.
    Lai WT, Lee HC, Huang YH, Lo MH, Kuo HC.
    BMC Pediatr; 2021 Mar 31; 21(1):157. PubMed ID: 33789621
    [Abstract] [Full Text] [Related]

  • 2. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
    Kuo HC, Yang YL, Chuang JH, Tiao MM, Yu HR, Huang LT, Yang KD, Chang WC, Lee CP, Huang YH.
    J Clin Immunol; 2012 Aug 31; 32(4):746-52. PubMed ID: 22392047
    [Abstract] [Full Text] [Related]

  • 3. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Aug 31; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 4. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, Xu XY, Zheng H.
    Zhonghua Er Ke Za Zhi; 2004 Sep 31; 42(9):688-92. PubMed ID: 15482673
    [Abstract] [Full Text] [Related]

  • 5. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
    Yang SW, Wang DW, Li J, Qin YM, Wang FM, Cao LM, Zhang LF, Hu Z.
    Zhonghua Er Ke Za Zhi; 2005 Aug 31; 43(8):612-5. PubMed ID: 16191276
    [Abstract] [Full Text] [Related]

  • 6. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Aug 31; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 7. Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.
    Sapountzi E, Fidani L, Giannopoulos A, Galli-Tsinopoulou A.
    Pediatr Cardiol; 2023 Jan 31; 44(1):1-12. PubMed ID: 35908117
    [Abstract] [Full Text] [Related]

  • 8. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.
    Oncotarget; 2017 Jan 10; 8(2):2044-2052. PubMed ID: 27893416
    [Abstract] [Full Text] [Related]

  • 9. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L, Zhang J, Zhong J, Zheng Y.
    J Interferon Cytokine Res; 2020 Mar 10; 40(3):159-167. PubMed ID: 31841639
    [Abstract] [Full Text] [Related]

  • 10. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.
    Pediatr Rheumatol Online J; 2019 Jul 19; 17(1):46. PubMed ID: 31324255
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J, Jiang H, Lu M.
    Arch Argent Pediatr; 2020 Oct 19; 118(5):327-331. PubMed ID: 32924395
    [Abstract] [Full Text] [Related]

  • 12. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
    Pediatr Neonatol; 2014 Oct 19; 55(5):387-92. PubMed ID: 24636168
    [Abstract] [Full Text] [Related]

  • 13. Expression of Fc<gamma>Rs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y, Tian X, Li Q, Wang G, Li C, Yang J.
    Int Immunopharmacol; 2017 Apr 19; 45():1-5. PubMed ID: 28147297
    [Abstract] [Full Text] [Related]

  • 14. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.
    J Microbiol Immunol Infect; 2007 Oct 19; 40(5):395-400. PubMed ID: 17932598
    [Abstract] [Full Text] [Related]

  • 15. [Risk factors for coronary artery lesions in children with Kawasaki disease].
    Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec 19; 14(12):938-41. PubMed ID: 23234782
    [Abstract] [Full Text] [Related]

  • 16. Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease.
    Chang LS, Chen KD, Huang YH, Kuo HC.
    Int J Mol Sci; 2022 Sep 03; 23(17):. PubMed ID: 36077487
    [Abstract] [Full Text] [Related]

  • 17. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.
    Wang CL, Wu YT, Liu CA, Lin MW, Lee CJ, Huang LT, Yang KD.
    Pediatrics; 2003 Feb 03; 111(2):E140-7. PubMed ID: 12563087
    [Abstract] [Full Text] [Related]

  • 18. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
    Wei M, Huang M, Chen S, Huang G, Huang M, Qiu D, Guo Z, Jiang J, Zhou X, Yu Q, Guo Y, Fu L, Gao W, Li F.
    Pediatr Cardiol; 2015 Aug 03; 36(6):1166-72. PubMed ID: 25812827
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
    Lei WT, Chang LS, Zeng BY, Tu YK, Uehara R, Matsuoka YJ, Su KP, Lee PC, Cavalcante JL, Stubbs B, Lin PY, Wu YC, Hsu CW, Chen TY, Chen YW, Yeh PY, Sun CK, Tseng PT, Kao YH.
    EBioMedicine; 2022 Apr 03; 78():103946. PubMed ID: 35306339
    [Abstract] [Full Text] [Related]

  • 20. [Changes in 25-hydroxyvitamin D3 level and its significance in children with Kawasaki disease].
    Zhang YD, Li RM, Ji CY, Zhang XL, Zhang Y, Dong QW, Ma L.
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar 03; 18(3):211-4. PubMed ID: 26975816
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.